India Regulator Sets Aug. 30 For 294 Licensed New Drugs Facing Ban
This article was originally published in PharmAsia News
Executive Summary
The Drug Controller General of India ordered the manufacturers of 294 new drugs that slipped by the approval process to prove their safety and efficacy by Aug. 30 or face a ban.